Mucocutaneous Lesions of Behcet's Disease

참고문헌 (81)

1. Sakane T, "Beh？et's disease", 341, pp.1284~1291 (1999)
2. Ehrlich GE, "Further studies of platelet rosettes around granulocytes in Beh？et's syndrome", pp.223~5
3. Lehner T, "Immunopathogenesis of Beh？et's disease", 150, pp.483~487 (1999), Paris
4. Alpsoy E, "HLA antigens and linkage disequilibrium patterns in Turkish Beh？et's patients", 25, pp.158~162 (1998)
5. Alpsoy E, "The levels of plasma interleukin-2 and soluble interleukin-2R in Beh？et's disease: as a marker of disease activity", 25, pp.513~516 (1998)
6. "International Study Group for Beh？et's Disease Criteria for diagnosis of Beh？et's disease", pp.1078~80
7. O'Neill TW, "Validation of the International Study Group criteria for Beh？et's disease", pp.115~7
8. Zouboulis CC, "Epidemiology of Adamantiades-Beh？et's disease", 150, pp.488~498 (1999), Paris
9. Zouboulis CC, "Adamantiades-Beh？et's disease: Epidemiology in Germany and in Europe. In: Lee S, Bang D, Lee E-S, Sohn S, editors. Beh？et's Disease. A Guide to its Clinical Understanding", pp.157~169 (2001), Berlin, Heidelberg: Springer
10. Mfto？lu AU, "lack of correlation of clinical manifestations with HLA antigens", pp.226~30
11. Yamamoto S, "A nation-wide survey of Beh？et's disease in Japan", pp.282~90
12. "Beh？et disease in Trkey", pp.1120~2
13. Grler A, "Clinical manifestations of Beh？et's disease: an analysis of 2147 patients", 38, pp.423~427 (1997)
14. Zouboulis CC, "Epidemiological features of Adamantiades-Beh？et's disease in Germany and in Europe", 38, pp.411~422 (1997)
15. Durusoy C, "Histological findings and androgen receptor levels in the sebaceous glands of papulopustular lesions from patients with Beh？et's disease and acne vulgaris: A Controlled Study", 6, pp.87~93 (2002)
16. Ann Rheum Dis 1984; 3, "Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Beh？et's syndrome", pp.783~9
17. Demiro？lu H, "Risk factor assessment and prognosis of eye involvement in Beh？et's disease in Turkey", 104, pp.701~705 (1997)
18. Yaz？c？ H, "The ten-year mortality in Beh？et's syndrome", 35, pp.139~141 (1996)
19. Alpsoy E, "Review of the chronology of clinical manifestations in 60 patients with Beh？et's disease", 207, pp.354~356 (2003)
20. Alpsoy E, "A randomized, controlled and blinded study of papulopustular lesions in Turkish Beh？et's patients", 37, pp.839~843 (1998)
21. Alpsoy E, "The use of sucralfate suspension in the treatment of oral and genital ulceration of Beh？et disease: a randomized, placebo-controlled, double-blind study", 135, pp.529~532 (1999)
22. Main DM, "Clinical differentiation of oral ulceration in Beh？et's disease", pp.767~70
23. Bang D, "Epidemiological and clinical features of Beh？et's disease in Korea", 38, pp.428~436 (1997)
24. Ghate JV, "Beh？et's disease and complex aphthosis", 40, pp.1~18 (1999)
25. Medicine, "Report of 41 cases and a review of the literature", pp.179~96 (1975)
26. Alpsoy E, "Interferon alpha-2a in the treatment of Beh？et disease: a randomized, placebo-controlled and double-blind study", 138, pp.467~471 (2002)
27. Greenberg MS, "HIV-associated lesions", 14, pp.319~326 (1996)
28. Taylor RS, "a forme fruste of Beh？et's syndrome? J Am Acad Dermatol 1985;13", pp.80~4
29. Kurban AK, "New perspectives on an enigmatic syndrome", pp.767~79
30. Ergun T, "Histopathologic features of the spontaneous pustular lesions of Beh？et's syndrome", 37, pp.194~196 (1998)
31. Jorizzo JL, "Mucocutaneous criteria for the diagnosis of Beh？et's disease: an analysis of clinicopathologic data from multiple international centers", 32, pp.968~976 (1995)
32. Alpsoy E, "Histologic and immunofluorescence findings of non-follicular papulopustular lesions in patients with Beh？et's disease", 17, pp.521~524 (2003)
33. Kim B, "Histopathologic features of erythema nodosum-like lesions in Beh？et disease: a comparison with erythema nodosum focusing on the role of vasculitis", 22, pp.379~390 (2000)
34. Chun SI, "Erythema nodosum- like lesions in Beh？et's syndrome a histopathologic study of 30 cases", pp.259~65
35. Ko？ Y, "Vascular involvement in Beh？et's disease", pp.402~10
36. "Beh？et's syndrome with obstruction of the venae cavae A report of seven cases", pp.151~68
37. "Abdominal aortic aneurysm with inferior vena cava obstruction", pp.227~32
38. Mustafa SO, "A new kind of skin lesion in Beh？et's disease"
39. Krger K, "Juvenile Adamantiades-Beh？et disease in decreased stimulation with anti-CD3 monoclonal antibody", 48, pp.258~261 (1997)
40. Treudler R, "Twenty-eight cases of juvenile-onset Adamantiades-Beh？et disease in Germany", 199, pp.15~19 (1999)
41. Alta？ M, "The validity of the pathergy test a double-blind study by independent observers", (n-specific skin hyperreactivity), pp.158~9
42. Ergun T, "The histopathology of pathergy: a chronologic study of skin hyperreactivity in Beh？et's disease", 37, pp.929~933 (1998)
43. Solomon AR, "Immunopathologic and histopathologic assessment of pathergy lesions is useful in diagnosis and follow-up", pp.747~51
44. Fresko I, "Effect of surgical cleaning of the skin on the pathergy phenomenon in Beh？et's syndrome", pp.619~20
45. O？uz O, "associated with Beh？et's disease", pp.645~6
46. Cho KH, "Beh？et's disease with Sweet's syndrome-like presentation-a report of six cases", pp.20~4
47. Armas JB, "Atypical Beh？et's disease with peripheral erosive arthropathy and pyoderma gangrenosum", pp.177~80
48. Lee ES, "Dermatologic manifestation of Beh？et's disease", 38, pp.380~389 (1997)
49. Golan G, "Henoch-Schonlein purpura-like disease representing a flare of Beh？et's disease", pp.1198~9
50. Cornelis F, "Beh？et's disease with severe cutaneous necrotizing vasculitis response to plasma exchange-report of a case", pp.576~9
51. Cantini F, "Beh？et's disease with unusual cutaneous lesions", 25, pp.2469~2472 (1998)
52. Liao YH, "Beh？et's disease with cutaneous changes resembling polyarteritis nodosa", 140, pp.368~369 (1999)
53. King R, "Acral purpuric papulonodular lesions as a manifestation of Beh？et's disease", 34, pp.190~192 (1995)
54. Kienbaum S, "a new histopathological pattern of vasculitis found in mucocutaneous lesions of patients with Adamantiades-Beh？et's disease", orfa(s ce), pp.337~41
55. Tani K, "Pathologic features of Beh？et's syndrome a review of Japanese autopsy registry data", pp.790~5
56. Kienbaum S, "Papulopustular skin lesions in Adamantiades-Beh？et's disease show a similar histopathological pattern as the classical mucocutaneous manifestations", orfa(s ce), pp.331~6
57. Zouboulis CC, "Adamantiades- Beh？et's disease: Interleukin-8 is increased in serum of patients with active oral and neurological manifestations and is secreted by small vessel endothelial cells", 292, pp.279~284 (2000)
58. Treudler R, "Enhanced interaction of patients' lymphocytes with human dermal microvascular endothelial cell cultures in active Adamantiades-Beh？et disease", 132, pp.1323~1329 (1996)
59. Kurz K, "necrotizing systemic vasculitis with a fatal outcome", orfa(s ce), pp.451~4
60. Gamble CN, "The immune complex pathogenesis of glomerulonephritis and pulmonary vasculitis in Beh？et's disease", pp.1031~9
61. Hay D, "The use of an elimination diet in the treatment of recurrent aphthous ulceration of the oral cavity", pp.504~7
62. Greer RO, "A double-blind study of topically applied 5% amlexanox in the treatment of aphthous ulcers", pp.243~9
63. Matthews RW, "Clinical evaluation of benzydamine and placebo mouthwashes in the management of recurrent aphthous stomatitis"
64. Kingman A, "Double-blind trial of tetracycline in recurrent aphthous ulceration", pp.376~82
65. Collier PM, "a treatment for aphthous ulcers", topical 5- ami(salicylic acid)
66. Hamuryudan V, "Azathioprine in Beh？et's syndrome: effects on long-term prognosis", 40, pp.769~774 (1997)
67. "Treatment of Beh？et's disease with indomethacin", pp.54~7
68. Yasui K, "Successful treatment of Beh？et's disease with pentoxifylline", 124, pp.891~893 (1996)
69. Chandrasekhar J, "Oxypentifylline in the management of recurrent aphthous oral ulcers: an open clinical trial", 87, pp.564~567 (1999)
70. Yurdakul S, "A double-blind trial of colchicine in Beh？et's syndrome", 44, pp.2686~2692 (2001)
71. Sharquie KE, "Suppression of Beh？et's disease with dapsone", pp.493~4
72. Zouboulis CC, "Treatment of Adamantiades- Beh？et disease with systemic interferon alfa", 134, pp.1010~1016 (1998)
73. Katsantonis J, "Xenobiotic regulation of endothelial intracellular and secreted interleukin-8 induced by serum of patients with Adamantiades- Beh？et's disease. In: Bang D, Lee E-S, Lee S, editors. Beh？et's Disease. Proceedings of the 9th International Conference on Beh？et's Disease and the 8th International Conference on Beh？et's Disease", pp.236~239 (2001)
74. Barnes CG, "A controlled trial of azathioprine in Beh？et's syndrome", pp.281~5
75. Avc？ O, "Efficacy of cyclosporine on mucocutaneous manifestations of Beh？et's disease", 36, pp.796~797 (1997)
76. White WL, "Low-dose weekly methotrexate for unusual neutrophilic vascular reactions", za(lli md), pp.973~8
77. Solomon AR, "Thalidomide effects in Beh？et's syndrome and pustular vasculitis", pp.878~81
78. Hamuryudan V, "Thalidomide in the treatment of the mucocutaneous lesions of the Beh？et syndrome. A randomized, double-blind, placebo-controlled trial", 128, pp.443~450 (1998)
79. Goossens PH, "Remission of Beh？et's syndrome with tumour necrosis factor alpha blocking therapy", 60, pp.637~ (2001)
80. Travis SP, "Treatment of intestinal Beh？et's syndrome with chimeric tumour necrosis factor alpha antibody", 49, pp.725~728 (2001)
81. Robertson LP, "Treatment of recalcitrant orogenital ulceration of Beh？et's syndrome with infliximab", 40, pp.473~474 (2001), Oxford

관련 논문AI추천